Literature DB >> 20004010

Effects of age, weight, hormones, and hibernation on breeding success in boreal toads (Bufo boreas boreas).

T L Roth1, D C Szymanski, E D Keyster.   

Abstract

The goals of this study were to test the effects of exogenous hormones and hibernation on breeding behavior and gamete release by boreal toads (Bufo boreas boreas). Each year, a subset of 77 toads was hibernated and then paired with hibernated or nonhibernated mates and treated with luteinizing hormone releasing hormone analogue (LHRHa), human chorionic gonadotropin (hCG), or left untreated. Amplexus and egg and sperm production were recorded. At 1 yr of age, only 19% of pairs exhibited amplexus, and no sperm or eggs were produced. At 2 and 3 yr of age, most male toads treated with LHRHa exhibited amplexus (56.9% and 100%, respectively). Among 2-yr-old males, amplexus was more prevalent (P<0.05) in those that were hibernated than in those that were nonhibernated (54.0% and 33.3%, respectively), but most males in each group (93.3% and 75%, respectively) produced sperm in response to LHRHa treatment. Only one 2-yr-old and two 3-yr-old females produced eggs. At 4 yr of age, eight females produced eggs, but two died from egg retention. More nonhibernated than hibernated females developed eggs (7 of 10 vs. 1 of 10, P<0.05). Mean (+/-SD) weight of female toads producing eggs (58.9 +/- 11.9g) was greater (P<0.05) than that of nonproducing females (43.6 +/- 7.0g). Similarly, four of seven nonhibernated females (58.8+/-8.3g) produced eggs at 5 yr of age. All eggs were produced by females treated once with LHRHa. Number of eggs per female varied (141 to 3307), and development to tadpoles was low (0 to 36.5%), although tadpoles did become toadlets. In conclusion, male and female boreal toads matured at 2 and 4 yr of age, respectively, and heavier females were more likely to produce eggs. To enhance breeding success, males should be hibernated and treated with LHRHa. In contrast, female productivity was enhanced by improving their body condition instead of subjecting them to hibernation prior to LHRHa treatment. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20004010     DOI: 10.1016/j.theriogenology.2009.09.033

Source DB:  PubMed          Journal:  Theriogenology        ISSN: 0093-691X            Impact factor:   2.740


  6 in total

1.  Evaluation of different temporal periods between hormone-induced ovulation attempts in the female Fowler's toad Anaxyrus fowleri.

Authors:  Emmet L Guy; Michelle W Martin; Andrew J Kouba; Judith A Cole; Carrie K Kouba
Journal:  Conserv Physiol       Date:  2020-01-09       Impact factor: 3.079

2.  Hormonal induction of gamete release, and in-vitro fertilisation, in the critically endangered southern corroboree frog, Pseudophryne corroboree.

Authors:  Phillip G Byrne; Aimee J Silla
Journal:  Reprod Biol Endocrinol       Date:  2010-11-29       Impact factor: 5.211

3.  Multi-omics analysis reveals that natural hibernation is crucial for oocyte maturation in the female Chinese alligator.

Authors:  Jian-Qing Lin; Jun Yu; Hua Jiang; Yi Zhang; Qiu-Hong Wan; Sheng-Guo Fang
Journal:  BMC Genomics       Date:  2020-11-10       Impact factor: 3.969

4.  Amphibian reproductive technologies: approaches and welfare considerations.

Authors:  Aimee J Silla; Natalie E Calatayud; Vance L Trudeau
Journal:  Conserv Physiol       Date:  2021-03-16       Impact factor: 3.079

5.  A comparison of human chorionic gonadotropin and luteinizing hormone releasing hormone on the induction of spermiation and amplexus in the American toad (Anaxyrus americanus).

Authors:  Andrew J Kouba; Javier delBarco-Trillo; Carrie K Vance; Callie Milam; Meghan Carr
Journal:  Reprod Biol Endocrinol       Date:  2012-08-20       Impact factor: 5.211

6.  Hormonal induction of spermiation in a Eurasian bufonid (Epidalea calamita).

Authors:  Lucía Arregui; Sergio Diaz-Diaz; Elia Alonso-López; Andrew J Kouba
Journal:  Reprod Biol Endocrinol       Date:  2019-11-11       Impact factor: 5.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.